Treatment of Crimean-Congo Hemorrhagic Fever With Supportive Care, Favipiravir, and Avatrombopag.

Clin Infect DisOct 28, 2026

Germán Ramírez-Olivencia, Miriam Estébanez, Tatiana Mata Forte et al.

✦ AI-curated · Sources linked

Case in brief

A patient with severe Crimean-Congo hemorrhagic fever was managed in a high-level isolation unit with supportive care, favipiravir, and avatrombopag. The report describes rapid platelet recovery, reduced transfusion requirements, and viral clearance during this multimodal treatment. The abstract does not provide further clinical or diagnostic details.

What made this case unusual

The case combined an antiviral with a thrombopoietin receptor agonist for severe CCHF-associated coagulopathy; the reported clinical course included rapid platelet recovery and reduced transfusion requirements.

Diagnostic / clinical pearl

In this reported severe CCHF case, favipiravir and avatrombopag were used alongside supportive care, with platelet recovery and viral clearance observed; the report does not establish the contribution of each intervention.

Source

Published in Clin Infect Dis. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Infectious Diseases

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.